Drug Discovery and Development Analysis & Statistics, January 2013 (p30)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

871-910 of about 2 800 reports

Purchase Reports From Reputable Market Research Publishers

AMPA Receptor Agonists -Pipeline Insights, 2014

AMPA Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“AMPA Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
AMPA Receptor Antagonists -Pipeline Insights, 2014

AMPA Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“AMPA Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
AMPK Beta Activators -Pipeline Insights, 2014

AMPK Beta Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“AMPK Beta Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
AMPK Beta Inhibitors -Pipeline Insights, 2014

AMPK Beta Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“AMPK Beta Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Angiopoietin 1 (Ang-1) Inhibitors -Pipeline Insights, 2014

Angiopoietin 1 (Ang-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiopoietin 1 (Ang-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Angiopoietin 2 (Ang-2) Inhibitors -Pipeline Insights, 2014

Angiopoietin 2 (Ang-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiopoietin 2 (Ang-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Angiopoietin Inhibitors -Pipeline Insights, 2014

Angiopoietin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiopoietin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Angiotensin II Receptor Inhibitors -Pipeline Insights, 2014

Angiotensin II Receptor Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin II Receptor Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors -Pipeline Insights, 2014

Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists -Pipeline Insights, 2014

Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitors -Pipeline Insights, 2014

Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Angiotensin Inhibitors -Pipeline Insights, 2014

Angiotensin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Angiotensin Receptor Agonists -Pipeline Insights, 2014

Angiotensin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Anti-Lymphotoxin -Pipeline Insights, 2014

Anti-Lymphotoxin -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-Lymphotoxin-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Antithrombin Activators -Pipeline Insights, 2014

Antithrombin Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Antithrombin Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Apolipoprotein B (ApoB) Inhibitors -Pipeline Insights, 2014

Apolipoprotein B (ApoB) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Apolipoprotein B (ApoB) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Apoptosis Inhibitors -Pipeline Insights, 2014

Apoptosis Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Apoptosis Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Arginine Depletors -Pipeline Insights, 2014

Arginine Depletors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Arginine Depletors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
ATPase Inhibitors -Pipeline Insights, 2014

ATPase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ATPase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Beta-2 Receptors Agonists -Pipeline Insights, 2014

Beta-2 Receptors Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Beta-2 Receptors Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Beta-3 Receptors Agonists -Pipeline Insights, 2014

Beta-3 Receptors Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Beta-3 Receptors Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Beta-Lactamase Inhibitors -Pipeline Insights, 2014

Beta-Lactamase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Beta-Lactamase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Bradykinin Antagonists -Pipeline Insights, 2014

Bradykinin Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Bradykinin Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Bradykinin Receptor B1 Antagonists -Pipeline Insights, 2014

Bradykinin Receptor B1 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Bradykinin Receptor B1 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Bradykinin Receptor B2 Antagonists -Pipeline Insights, 2014

Bradykinin Receptor B2 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Bradykinin Receptor B2 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Brain Derived Neurotrophic Factor (BDNF) Modulators -Pipeline Insights, 2014

Brain Derived Neurotrophic Factor (BDNF) Modulators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Brain Derived Neurotrophic Factor (BDNF) Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Brutons Tyrosine Kinase (Btk) Inhibitors -Pipeline Insights, 2014

Brutons Tyrosine Kinase (Btk) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Brutons Tyrosine Kinase (Btk) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
C1 Esterase Inhibitors -Pipeline Insights, 2014

C1 Esterase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“C1 Esterase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
C5a Receptor Antagonists -Pipeline Insights, 2014

C5a Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“C5a Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Carbonic Anhydrase 1 (CA1) Inhibitors -Pipeline Insights, 2014

Carbonic Anhydrase 1 (CA1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Carbonic Anhydrase 1 (CA1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development

84 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.